www.dragorosso.com
Open in
urlscan Pro
34.234.52.18
Public Scan
Submitted URL: https://dragorosso.com/
Effective URL: https://www.dragorosso.com/
Submission: On July 19 via automatic, source certstream-suspicious — Scanned from CA
Effective URL: https://www.dragorosso.com/
Submission: On July 19 via automatic, source certstream-suspicious — Scanned from CA
Form analysis 0 forms found in the DOM
Text Content
Documentation Pitch Deck White Paper Executive SUmmary Business Plan See Study Paper About Partners spectroscopy TeCh Team Investors Blog Blog 1 Blog 2 Blog 3 (coming soon) Contact Email 310.924.2070 ONE MINUTE TO LEARN ABOUT YOUR HEART HEALTH. No matter who you are, whether you are sick or well, you just breathe through our mask normally for one minute, and we analyze a mixture of inhaled and exhaled gases, to discover changes in your health, providing accurate data for use in check-ups, urgent medical situations, drug therapy assessment and even athletic training, to proactively improve your health and wellbeing. Read the Pitch Deck CONTACT US +1 310 924 2070 johng@dragorosso.com LOCATION 140 W. Chestnut Ave. Monrovia, CA 91016 FUNDRAISING - SEED ROUND S.A.F.E. investing document available upon request. YOU MAY BE LOOKING FOR: Pitch Deck White Paper Business Plan Executive Summary LIST OF PARTNERS Dragorosso’s technology was invented by the founders of the Oak Crest Institute of Science, where they work with the most distinguished academic research partners. TRIALS COMPLETED Dragorosso completed their first round of clinical study several years ago and is currently about to embark on further clinical studies in 2023 with ten major research partners. These studies will provide ample evidence of the accuracy and merit of the Dragorosso technology PATENTS ISSUED Dragorosso is the assignee of the original patent covering the device. Dragorosso will apply for a new patent in 2023, extending the protection of the family of technologies. REIMAGINING CARE Dragorosso's One Minute Test can: * Save Lives: the non-invasive test replaces a more hazardous, invasive procedure for cardiopulmonary patients * Save Cost: an inexpensive test versus steep thousands of dollars in medical bills per patient * Save a Heart Failure outpatient from being admitted to hospital to stabilize their condition. * Save Beds in Hospitals * Save health system and insurers over Ten billion dollars a year in the US alone Meet Our TeamDiagnostic Paper INVESTING PAPERS PITCH DECK Short 12-page presentation to provide a concise snapshot of Dragorosso. WHITE PAPER A look at Dragorosso's non-invasive measurement of cardiopulmonary performance BUSINESS PLAN Overview of business plan, investment opportunities, and financial forecast. 1 MIN CLINICAL EXAM Our non-invasive one minute exam is simple and provides more data on cardiac output over any other exam on the market. 1 PATENT We have secured a crucial patent pertaining to our groundbreaking testing technology. Patent detail available upon request. 1 DIAGNOSTIC STUDY Real individual data to study Dragorosso's effectiveness available. See Study Paper. MEET OUR TEAM JOHN GUIDON Chief Executive Officer BSc. in electrical engineering from Imperial College with repeated success in founding and leading VC and PE backed technology startups to exits for investors by acquisition or going public. Expert at managing growth of technology startups to exit MARC BAUM Chief Science Officer Ph.D. in organic chemistry from Imperial College, extensive record as principal investor on federally and locally funded research grants and contracts, including NIH, NSF, Dept. of Defense, Dept. of Agriculture, AQMD, HEI, etc. Co-founder of Oak Crest Institute of Science. Expert in spectroscopy, instrumentation design, clinical trial design and implementation, regulatory affairs JOHN MOSS Chief Technology Officer Ph.D. in chemistry from UNC, Chapel Hill, postdoctoral fellow at Caltech in Engineering and Applied Science. Co-founder of Oak Crest Institute of Science. Principal investigator on NIH and NSF research grants. Expert at laser spectroscopy, optical and analytical instrumentation design and development, optomechanical device miniaturization, advanced manufacturing techniques, and cardiopulmonary chemistry FROM OUR BLOG LEARN MORE DECEMBER 6, 2022 THE BEAT GOES ON: PROACTIVE CARDIAC CARE Healthy people think of the heart as a reliable pump that can have disastrous failures if we don’t manage our health. Good enough to last a lifetime, but easily damaged by bad choices with behavior, diet, and drugs. Using technology, we will improve our medical approach to cardiac care, improving lives, reducing costs, and avoiding bad outcomes. LEARN MORE DECEMBER 6, 2022 THE US SHOULD INVEST IN TELEMEDICINE AND PROACTIVE MEDICINE Telemedicine and proactive health screenings can give us better health outcomes and save enormous amounts of money, translating into extraordinary returns for investors buying into this vision. INTERESTED TO LEARN MORE? Virtually meet the team. Schedule a Meeting Feel free to contact us if you have any questions “Giving you and your doctor the best tools to ensure the best healthcare and well-being outcomes.”